搜尋結果
衝擊波醫療（NASDAQ：SWAV-獲得評級）在周四向客戶和投資者發布的一份研究報告中，派珀·桑德勒的價格目標從300.00 美元下降至 280.00 美元，《蒼蠅》報告
衝擊波醫療公司(納斯達克代碼：SWAV-GET評級)首席財務官丹·帕克特在9月20日(星期二)的一筆交易中出售了1,100股衝擊波醫療公司的股票。 這隻股票的平均售價是
- Shockwave Medical Insider Transactions Over The Last Year
- Shockwave Medical Insiders Are Selling The Stock
- Insider Ownership
- So What Does This Data Suggest About Shockwave Medical Insiders?
The Chief Commercial Officer, Isaac Zacharias, made the biggest insider sale in the last 12 months. That single transaction was for US$861k worth of shares at a price of US$222 each. So what is clear is that an insider saw fit to sell at around the current price of US$212. While we don't usually like to see insider selling, it's more concerning if ...
The last three months saw significant insider selling at ShockWave Medical. In total, insiders sold US$1.3m worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. ShockWave Medical insiders own 1.7% of the company, currently worth about US$131m based on the recent share price. This kind of sig...
Insiders sold ShockWave Medical shares recently, but they didn't buy any. And even if we look at the last year, we didn't see any purchases. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facin...
衝擊波醫療股份有限公司（NASDAQ：SWAV-獲取評級）董事弗蘭克·沃特金斯在2 月 21 日（星期二）進行的交易中出售了 3,000 股衝擊波醫療股票。股份被賣出
衝擊波醫療有限公司（NASDAQ：SWAV-獲取評級）的股價在星期三下跌了4.5％。該公司的交易價格低至 188.38 美元，最後交易價為 189.40 美元。169,059 股股份在日中期交易手
衝擊波醫療(納斯達克：SWAVGET評級)和Artivion(紐約證券交易所代碼：AORT-GET評級)都是醫療公司，但哪隻股票更好？ 我們將根據這兩家公司的實力進行比較。
根據其最近向證券和證券提交的文件，海港投資諮詢有限責任公司在第四季度將其在衝擊波醫療公司（NASDAQ：SWAV-獲得評級）的股份減少了15.6％
